Circulating skin-homing T cells in atopic dermatitis: Selective up- regulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy

Archives of Dermatology

Volumn 132, Issue 10, 1996, Pages 1171-1176

  Piletta, Pierre A ^a   Wirth, Susanne ^b   Hommel, Lucette ^a   Saurat, Jean H ^a   Hauser, Conrad ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Hopital Cantonal   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; HUMAN; LYMPHOCYTE ACTIVATION; PHOTOTHERAPY; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ADOLESCENT; ADULT; ANTIGENS, CD30; ANTIGENS, NEOPLASM; DERMATITIS, ATOPIC; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECEPTORS, LYMPHOCYTE HOMING; SKIN; T-LYMPHOCYTE SUBSETS; ULTRAVIOLET THERAPY; UP-REGULATION;

EID: 0029853719     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.132.10.1171     Document Type: Article

References (29)

1. Muller KM, Hauser C. The biological and clinical significance of helper T-cell subsets in the human. Exp Dermatol. 1992;1:161-169.
2. Grewe M, Gyufko K, Schopf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet. 1994;343:25-26.
3. Ohmen JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol. 1995;154:1956-1963.
4. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration the multistep paradigm. Cell. 1994;76:301-314.
5. Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans. Am J Pathol. 1990;136:1053-1063.
6. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC. ELAM-1 is an adhesion molecule for skin-homing. T cells. Nature. 1991;349:796-799.
7. Santamaria Babi LF, Moser R, Perez Soler MT, Picker LJ, Blaser K, Hauser C. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol. 1995;154:1543-1550.
8. Groves RW, Ross EL, Barker JN, MacDonald DM. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol. 1993;29:67-72.
9. Picker LJ, Treer JR, Ferguson Darnell B, Collins PA, Bergstresser PR, Terstappen LW. Control of lymphocyte recirculation in man, II: differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol. 1993;150:1122-1136.
10. Picker LJ, Martin RJ, Trumble A, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol. 1994;24:1269-1277.
11. Rossiter H, Van Reijsen F, Mudde GC, et al. Skin disease-related T cells bind to endothelial selectins: expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol. 1994;24:205-210.
12. Santamaria Babi LF, Picker LJ, Perez Soler MT, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med. 1995;181:1935-1940.
13. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92:44-47.
14. Fitzpatrick TB. The validity and practicality of sun-reaction skin types I through VI. Arch Dermatol. 1988;124:869-871.
15. Costa C, Rilliet A, Nicolet M, Saurat JH. Scoring atopic dermatitis, the simpler the better? Acta Derm Venereol. 1989;69:41-45.
16. Finlay AY, Khan GK. Dermatology Life Quality Index (DLOI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-216.
17. Jekler J, Larkö O. Combined UVA-UVB versus UVB phototherapy for atopic dermatitis: a paired-comparison study. J Am Acad Dermatol. 1990;22:49-53.
18. Midelfart K, Stenvold SE, Volden G. Combined UVB and UVA phototherapy of atopic eczema. Dermatologica. 1985;171:95-98.
19. Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic patients. Dermatology. 1992;185:88-92.
20. Czech W, Krutmann J, Schöpf E, Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol. 1992;126:351-355.
21. Wuthrich B. Serum IgE in atopic dermatitis. Clin Allergy. 1978;8:241-247.
22. Byrom NA, Timlin DM. Immune status in atopic eczema: a survey. Br J Dermatol. 1979;100:491-498.
23. Juhlin L, Johansson SGO, Bennich H, Högman C, Thyresson N. Immunoglobulin E in dermatoses: level in atopic dermatitis and urticaria. Arch Dermatol. 1969;100:12-16.
24. Chiarelli F, Canfora G, Verrotti A, Amerio P, Morgese G. Humoral and cellular immunity in children with active and quiescent atopic dermatitis. Br J Darmatol. 1987;116:651-660.
25. Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today. 1994;15: 479-483.
26. Newman R, Schneider C, Sutherland R, Vodinelich L, Greaves M. The transferrin receptor. Trends Biochem Sci. 1982;1:397-400.
27. Del Prete G, Maggi E, Pizzolo G, Romagnani S. CD30, Th2 cytokines and HIV infection: a complex and fascinating link. Immunol Today. 1995;16:76-80.
28. Gruss HJ, Boiani N, Williams DE, Armitage RJ, Smith CA, Goodwin RG. Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood. 1994;83:2045-2056.
29. Smith CA, Gruss HJ, Davis T, et al. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 1993;73:1349-1360